| Product Information |
BR-1271_PI_01.pdf
|
| Registration Number |
BR-1271
|
| Generic Name |
Insulin Glargine/ Lixisenatide
|
| Brand Name |
Soliqua
|
| Dosage Strength |
3.64 mg (equivalent to 100 Units of Insulin glargine) / 33 mcg per mL
|
| Dosage Form |
Solution for Injection (SC)
|
| Classification |
Prescription (Rx) Drug
|
| Packaging |
3 mL-net content Type I glass cartridge with black bromobutyl rubber plunger stopper, aluminum flanged cap with punched laminated sealing disk assembled into a disposable pen-injector made of polypropylene (Box of 1's, 3's and 5's).
|
| Pharmacologic Category |
Long-acting Insulin and Analogue
|
| Manufacturer |
Sanofi-Aventis Deutschland GmbH
|
| Country of Origin |
Germany
|
| Trader |
|
| Importer |
Sanofi-Aventis Philippines, Inc.
|
| Distributor |
Sanofi-Aventis Philippines, Inc.
|
| Application Type |
Initial (from Monitored Release)
|
| Issuance Date |
06 March 2024
|
| Expiry Date |
09 May 2028
|